Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)

Centre Hospitalier de la côte Basque307 enrolled

Overview

Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.

Study of seroprevalence of hepatitis E among patient followed and treated in "centre Hospitalier de la Côte Basque" for HIV infections. Study of acquisition of hepatitis E , and determination of liver status using fibrotest in co-infected patients with hepatis C and / or B.

Study Type

OBSERVATIONAL

Enrollment

307

Conditions

HIV Hepatitis E

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * HIV positive \> 18 Exclusion Criteria: * patient refusal for participation

Locations (1)

Centre hospitalier de la Côte Basque

Bayonne, France

Outcomes

Primary Outcomes

Prevalence of immunoglobulin M (IgM) and Immunoglobulin G (IgG) for hepatitis E in blood sample of each patients. Positive sample for both IgM and IgG will be confirmed using polymerase chain reaction (PCR) techniques

Blood samples will be tested for specific immunoglobulins against hepatitis E virus

Time frame: 6 months time period

Secondary Outcomes

fibrotest score

patients infected with hepatitis B or hepatitis C viruses will have their liver status determined using fibrotest score.

Time frame: 6 months time period

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.